MRD


Also found in: Dictionary, Thesaurus, Financial, Acronyms, Wikipedia.

MRD

, mrd
Abbreviation for minimal reacting dose.

MRD

Abbreviation for:
matched related donor
maximum rate of depolarisation
medical records department
medical renal disease
minimum renal disease
minimum residual disease
mortality rate doubling (see there)
multicystic renal dysplasia

MRD

Abbreviation for minimal reacting dose.
References in periodicals archive ?
Overall, researchers showed that regardless of other risk factors, including age at diagnosis or the initial white blood cell count, patients with an MRD level of 1 percent or more on day 19 of therapy were far less likely than other young leukemia patients to be alive and cancer-free 10 years later.
In short, much better disease management is provided through molecular MRD monitoring.
Last year, Congress passed the Worker, Retiree, and Employer Recovery Act of 2008 ("WRERA"), aka PL 110-458 (December 23, 2008), which generally makes technical corrections to the Pension Protection Act of 2006 ("PPA 2006"), aka PL 109-280 (August 17, 2006), and suspends the MRDs for the 2009 tax year.
In that case, the MRD and taxes will be the same as under the old rules.
For MRD analysis, 990-[micro]L portions from each urine sample were transferred to 1.
The results reported by Hillmen et al demonstrate that reduction in MRD below the level of detectability is achievable in CLL.
A QTIP trust often will pay out the MRD to the beneficiary to reduce both income and estate taxes.
In that situation, the MRD is based on a longer payout period, resulting in a smaller MRD.
One study, which was published today in the online version of BLOOD, showed that the LymphoSIGHT[TM] method detected MRD in patient samples that originally tested negative by flow cytometry and polymerase chain reaction (PCR).
SEATTLE, April 1, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced publication of a study in The Lancet Oncology showing that analysis of circulating tumor DNA (ctDNA) using the company's next-generation sequencing-based minimal residual disease (MRD) detection and quantification technology (available clinically as the clonoSEQ(TM) MRD test) accurately identifies patients with diffuse large B-cell lymphoma (DLBCL) who are at risk of relapse after initial treatment, usually several months before disease can be detected via computed tomography (CT).